BASF and Oxidium Technologies LLC complete sale and purchase transaction for Aseptrol biocide business
March 18, 2026
March 18, 2026
FLORHAM PARK, New Jersey, March 18 [Category: Industrial Materials] -- BASF Corp. issued the following news release:
* * *
BASF and Oxidium Technologies LLC complete sale and purchase transaction for Aseptrol biocide business
*
* BASF to divest Aseptrol chlorine dioxide portfolio to Oxidium, an affiliate of Quip Laboratories; financial terms undisclosed
* Acquisition positions Aseptrol's chlorine dioxide technology for expa . . .
* * *
BASF and Oxidium Technologies LLC complete sale and purchase transaction for Aseptrol biocide business
*
* BASF to divest Aseptrol chlorine dioxide portfolio to Oxidium, an affiliate of Quip Laboratories; financial terms undisclosed
* Acquisition positions Aseptrol's chlorine dioxide technology for expa . . .
